Thyrocare Technologies Limited (THYROCARE) - Total Liabilities
Based on the latest financial reports, Thyrocare Technologies Limited (THYROCARE) has total liabilities worth Rs1.61 Billion INR (≈ $17.43 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Thyrocare Technologies Limited strategic investment ratio to see how much of total assets are deployed in long-term investments.
Thyrocare Technologies Limited - Total Liabilities Trend (2011–2026)
This chart illustrates how Thyrocare Technologies Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Thyrocare Technologies Limited assets under control.
Thyrocare Technologies Limited Competitors by Total Liabilities
The table below lists competitors of Thyrocare Technologies Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Science Environmental Protection Co. Ltd. A
SHG:688480
|
China | CN¥817.92 Million |
|
NCR Voyix Corporation
NYSE:VYX
|
USA | $2.72 Billion |
|
Biotest Aktiengesellschaft
XETRA:BIO
|
Germany | €906.90 Million |
|
Whitestone REIT
NYSE:WSR
|
USA | $698.32 Million |
|
Brookline Bancorp Inc
NASDAQ:BRKL
|
USA | $10.31 Billion |
|
Allianz Malaysia Bhd
KLSE:1163
|
Malaysia | RM24.21 Billion |
|
Malion New Materials Co Ltd
SHE:300586
|
China | CN¥1.79 Billion |
|
Redcare Pharmacy NV
F:RDC
|
Germany | €735.10 Million |
Liability Composition Analysis (2011–2026)
This chart breaks down Thyrocare Technologies Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See THYROCARE equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Thyrocare Technologies Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Thyrocare Technologies Limited (2011–2026)
The table below shows the annual total liabilities of Thyrocare Technologies Limited from 2011 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs1.61 Billion ≈ $17.43 Million |
+10.64% |
| 2025-03-31 | Rs1.46 Billion ≈ $15.76 Million |
+25.33% |
| 2024-03-31 | Rs1.16 Billion ≈ $12.57 Million |
+19.23% |
| 2023-03-31 | Rs975.00 Million ≈ $10.54 Million |
+20.24% |
| 2022-03-31 | Rs810.90 Million ≈ $8.77 Million |
-31.58% |
| 2021-03-31 | Rs1.19 Billion ≈ $12.82 Million |
+15.44% |
| 2020-03-31 | Rs1.03 Billion ≈ $11.10 Million |
+159.27% |
| 2019-03-31 | Rs396.00 Million ≈ $4.28 Million |
+10.94% |
| 2018-03-31 | Rs356.96 Million ≈ $3.86 Million |
+23.00% |
| 2017-03-31 | Rs290.22 Million ≈ $3.14 Million |
-34.14% |
| 2016-03-31 | Rs440.64 Million ≈ $4.77 Million |
+133.28% |
| 2015-03-31 | Rs188.89 Million ≈ $2.04 Million |
-52.14% |
| 2014-03-31 | Rs394.68 Million ≈ $4.27 Million |
+8.35% |
| 2013-03-31 | Rs364.28 Million ≈ $3.94 Million |
+5.28% |
| 2012-03-31 | Rs346.01 Million ≈ $3.74 Million |
+3.56% |
| 2011-03-31 | Rs334.11 Million ≈ $3.61 Million |
-- |
About Thyrocare Technologies Limited
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical an… Read more